Research is ongoing to better understand the mechanisms by which tobacco-related mutagens cause genetic mutations and to develop strategies for prevention and treatment. Studies are focusing on identifying biomarkers for early detection of tobacco-induced mutations, as well as exploring gene-environment interactions that may influence susceptibility. New therapeutic approaches, including targeted therapies and personalized medicine, are also under investigation to treat mutations caused by tobacco exposure more effectively.
